Filing Details

Accession Number:
0000899243-18-014717
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-01 17:43:57
Reporting Period:
2018-05-30
Accepted Time:
2018-06-01 17:43:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352413 Christopher Mark Capone 20 Wakara Way
Salt Lake City UT 84108
President & C.e.o. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-30 90,000 $22.93 422,175 No 4 M Direct
Common Stock Disposition 2018-05-30 90,000 $38.00 332,175 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-05-30 90,000 $0.00 90,000 $22.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-30 2018-09-10 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.